San Francisco, CA · Founded 2019 · Privately Held (backing)
Developer of therapeutic enzymes designed for degrading molecular damage associated with aging. Revel Pharmaceuticals is based in San Francisco, CA and was founded in 2019. It was valued at $15 million at its early-stage round in Mar 2022, the last priced event on record. It has raised $14.7 million across 3 recorded rounds; the latest was a $5.8 million early-stage round in Feb 2022.
PMV mark · valuation
$15.0M
Oct 2026
Priced at
its early-stage round
Mar 2022
Total raised
$14.7M
Last round
Early Stage VC
Feb 2022
Team — not yet on record
No current team members for Revel Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Revel Pharmaceuticals with a free account
·Watch Revel Pharmaceuticals: the Monday email on marks, rounds and moves
